3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Prostatic Neoplasms
7
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Thrombocytosis
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Squamous Cell
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Liposarcoma
1
Interventions
Fluorouracil
26
Radiotherapy
18
Mitomycin
17
Cisplatin
12
Capecitabine
12
pembrolizumab
10
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
9
Radiation
8
Paclitaxel
8
Biopsy
8
fludarabine
7
Specimen Handling
7
Nivolumab
7
Drug Therapy
7
Carboplatin
7
Surveys and Questionnaires
6
Cetuximab
6
Papillomavirus Vaccines
5
dehydroftorafur
4
aldesleukin
4
Vaccines
4
Radiotherapy, Intensity-Modulated
4
Observation
4
Irinotecan
4
Watchful Waiting
3
Taxes
3
Oxaliplatin
3
Light Coagulation
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
enzalutamide
×
Gastrointestinal
×
Clear all
NCT05551117
2026-02-09
Tamarack
MacroGenics
Phase 2
Terminated
192 enrolled
20 charts